UCLA Medical Center Rheumatology

Topics

• Systemic Sclerosis and Related Diseases 180
• Rheumatoid Arthritis Research and Therapies 23
• Salivary Gland Disorders and Functions 14
• Systemic Lupus Erythematosus Research 11
• Inflammatory Myopathies and Dermatomyositis 8
• Bone health and osteoporosis research 6
• Complement system in diseases 5
• Monoclonal and Polyclonal Antibodies Research 5
• Pulmonary Hypertension Research and Treatments 5
• Eosinophilic Disorders and Syndromes 4
• Retinal and Optic Conditions 4
• Retinal Diseases and Treatments 4

Most cited

1. A phase 2b, randomized, double-blind, placebo-controlled, clinical trial of atacicept for treatment of IgA nephropathy.

   Kidney international · 2024 · 116 citations · Celia Lin

2. Macrophage fumarate hydratase restrains mtRNA-mediated interferon production.

   Nature · 2023 · 211 citations · Swamy Venuturupalli

3. Tocilizumab Prevents Progression of Early Systemic Sclerosis-Associated Interstitial Lung Disease.

   Arthritis & rheumatology (Hoboken, N.J.) · 2021 · 148 citations · Celia Lin

4. Long-Term Safety and Efficacy of Tocilizumab in Early Systemic Sclerosis-Interstitial Lung Disease: Open-Label Extension of a Phase 3 Randomized Controlled Trial.

   American journal of respiratory and critical care medicine · 2022 · 102 citations · Celia Lin

5. Genome-wide association study identifies Sjögren's risk loci with functional implications in immune and glandular cells.

   Nature communications · 2022 · 102 citations · Swamy Venuturupalli

6. Prognostic and predictive markers of systemic sclerosis-associated interstitial lung disease in a clinical trial and long-term observational cohort.

   Rheumatology (Oxford, England) · 2024 · 32 citations · Celia Lin